4/17
04:00 pm
cytk
Cytokinetics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Low
Report
Cytokinetics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
4/15
12:40 pm
cytk
Cytokinetics, Incorporated (NASDAQ: CYTK) had its price target lowered by analysts at Bank of America Co. from $62.00 to $54.00. They now have a "neutral" rating on the stock.
Low
Report
Cytokinetics, Incorporated (NASDAQ: CYTK) had its price target lowered by analysts at Bank of America Co. from $62.00 to $54.00. They now have a "neutral" rating on the stock.
4/15
11:05 am
cytk
Cytokinetics, Incorporated (NASDAQ: CYTK) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $120.00 price target on the stock.
Low
Report
Cytokinetics, Incorporated (NASDAQ: CYTK) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $120.00 price target on the stock.
4/10
11:20 am
cytk
Cytokinetics, Incorporated (NASDAQ: CYTK) had its "market outperform" rating re-affirmed by analysts at JMP Securities. They now have a $78.00 price target on the stock.
Medium
Report
Cytokinetics, Incorporated (NASDAQ: CYTK) had its "market outperform" rating re-affirmed by analysts at JMP Securities. They now have a $78.00 price target on the stock.
4/10
08:38 am
cytk
Imbria Pharmaceuticals Raises $57.5M Series B Financing Round and Appoints Alvin Shih, MD as CEO [Yahoo! Finance]
Medium
Report
Imbria Pharmaceuticals Raises $57.5M Series B Financing Round and Appoints Alvin Shih, MD as CEO [Yahoo! Finance]
4/8
08:40 am
cytk
Cytokinetics, Incorporated (NASDAQ: CYTK) had its "buy" rating re-affirmed by analysts at Needham & Company LLC. They now have a $72.00 price target on the stock.
Medium
Report
Cytokinetics, Incorporated (NASDAQ: CYTK) had its "buy" rating re-affirmed by analysts at Needham & Company LLC. They now have a $72.00 price target on the stock.
4/4
08:14 am
cytk
Cytokinetics, Incorporated (NASDAQ: CYTK) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $120.00 price target on the stock.
Medium
Report
Cytokinetics, Incorporated (NASDAQ: CYTK) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $120.00 price target on the stock.
4/2
03:23 pm
cytk
Edgewise Therapeutics Stock Plummets on Drug Trial 'Adverse Events' [Yahoo! Finance]
Low
Report
Edgewise Therapeutics Stock Plummets on Drug Trial 'Adverse Events' [Yahoo! Finance]
3/31
04:00 pm
cytk
Cytokinetics to Participate in the 24th Annual Needham Virtual Healthcare Conference
Medium
Report
Cytokinetics to Participate in the 24th Annual Needham Virtual Healthcare Conference
3/25
10:41 am
cytk
Cytokinetics (CYTK) Moves 5.4% Higher: Will This Strength Last? [Yahoo! Finance]
Low
Report
Cytokinetics (CYTK) Moves 5.4% Higher: Will This Strength Last? [Yahoo! Finance]
3/20
08:32 am
cytk
Cytokinetics Announces Launch of EARTH-HCM, a Public Health Education Tool for the Hypertrophic Cardiomyopathy Community [Yahoo! Finance]
Low
Report
Cytokinetics Announces Launch of EARTH-HCM, a Public Health Education Tool for the Hypertrophic Cardiomyopathy Community [Yahoo! Finance]
3/20
07:30 am
cytk
Cytokinetics Announces Launch of EARTH-HCM, a Public Health Education Tool for the Hypertrophic Cardiomyopathy Community
Low
Report
Cytokinetics Announces Launch of EARTH-HCM, a Public Health Education Tool for the Hypertrophic Cardiomyopathy Community
3/18
04:00 pm
cytk
Cytokinetics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Low
Report
Cytokinetics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
3/17
08:07 am
cytk
Cytokinetics Announces Five Presentations at the American College of Cardiology Annual Scientific Session & Expo [Yahoo! Finance]
Low
Report
Cytokinetics Announces Five Presentations at the American College of Cardiology Annual Scientific Session & Expo [Yahoo! Finance]
3/17
08:00 am
cytk
Cytokinetics Announces Five Presentations at the American College of Cardiology Annual Scientific Session & Expo
Low
Report
Cytokinetics Announces Five Presentations at the American College of Cardiology Annual Scientific Session & Expo
3/10
12:04 pm
cytk
Cytokinetics, Incorporated (NASDAQ: CYTK) was given a new $67.00 price target on by analysts at Morgan Stanley.
Low
Report
Cytokinetics, Incorporated (NASDAQ: CYTK) was given a new $67.00 price target on by analysts at Morgan Stanley.
3/3
04:00 pm
cytk
Cytokinetics to Participate in March Investor Conferences
Low
Report
Cytokinetics to Participate in March Investor Conferences
2/28
09:50 am
cytk
Cytokinetics Inc (CYTK) Q4 2024 Earnings Call Highlights: Revenue Surge Amidst Rising Expenses [Yahoo! Finance]
Low
Report
Cytokinetics Inc (CYTK) Q4 2024 Earnings Call Highlights: Revenue Surge Amidst Rising Expenses [Yahoo! Finance]
2/28
09:50 am
cytk
Cytokinetics (CYTK) Reports Q4 Loss, Misses Revenue Estimates [Yahoo! Finance]
Low
Report
Cytokinetics (CYTK) Reports Q4 Loss, Misses Revenue Estimates [Yahoo! Finance]
2/28
08:13 am
cytk
Cytokinetics, Incorporated (NASDAQ: CYTK) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $120.00 price target on the stock.
Low
Report
Cytokinetics, Incorporated (NASDAQ: CYTK) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $120.00 price target on the stock.
2/27
05:49 pm
cytk
Cytokinetics Reports Fourth Quarter 2024 Financial Results and Provides Business Update [Yahoo! Finance]
Low
Report
Cytokinetics Reports Fourth Quarter 2024 Financial Results and Provides Business Update [Yahoo! Finance]
2/27
04:00 pm
cytk
Cytokinetics Reports Fourth Quarter 2024 Financial Results and Provides Business Update
Medium
Report
Cytokinetics Reports Fourth Quarter 2024 Financial Results and Provides Business Update
2/20
12:05 pm
cytk
Cytokinetics (CYTK) May Report Negative Earnings: Know the Trend Ahead of Next Week's Release [Yahoo! Finance]
Low
Report
Cytokinetics (CYTK) May Report Negative Earnings: Know the Trend Ahead of Next Week's Release [Yahoo! Finance]
2/19
04:00 pm
cytk
Cytokinetics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
High
Report
Cytokinetics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
2/13
04:00 pm
cytk
Cytokinetics to Announce Fourth Quarter Results on February 27, 2025
High
Report
Cytokinetics to Announce Fourth Quarter Results on February 27, 2025